COMPARATIVE EVALUATION OF QUALITY OF LIFE OF PATIENTS WITH LAMBLIOSIS USING DIFFERENT THERAPY REGIMEN
Open randomize control trial was conducted to evaluate the effects of new original Sausalin, as additional agent to standard treatment, on health-related quality of life 40 patients with giardiasis. The questionnaire Gastrointestinal Symptom Rating Scale (GSRS) was answered before and after treatment for evaluation of quality of life. Patients with giardiasis in both groups had similar symptoms in all dimensions in GSRS. Quality of life of the respondents reduced mainly due to dyspeptic manifestations and pain. Combination treatment with Sausalin was more effective and safety than treatment with alone Metronidazole. This study confirms that Sausalin is effective and safety drug for alternative treatment of giardiasis.
Number of Views: 318
Category of articles:
Articles
Bibliography link
Е.А. Юхневич-Насонова, Р.Х. Бегайдарова, Ш.С. Калиева, Г.М. Мулдаева, Е.О. Полякова СРАВНИТЕЛЬНАЯ ОЦЕНКА КАЧЕСТВА ЖИЗНИ ПАЦИЕНТОВ С ЛЯМБЛИОЗОМ НА ФОНЕ РАЗЛИЧНЫХ РЕЖИМОВ ТЕРАПИИ //Наука и Здравоохранение 2014.№ 1. С. 48-50 E.A. Yukhnevich-Nasonova, R.Kh. Begaydarova, Sh.S. Kalieva, G.M. Muldaeva, E.O. Polyakova COMPARATIVE EVALUATION OF QUALITY OF LIFE OF PATIENTS WITH LAMBLIOSIS USING DIFFERENT THERAPY REGIMEN // Nauka i Zdravookhranenie. 2014.№ 1. С. 48-50 Е.А. Юхневич-Насонова, Р.Х. Бегайдарова, Ш.С. Калиева, Г.М. Мулдаева, Е.О. Полякова ЛЯМБЛИОЗДЫ ӘР ТҮРЛІ ПРЕПАРТАРММЕН ЕМДЕГЕНДЕ НАУҚАСТАРДЫҢ ӨМІР СУРУ САПАСЫНЫҢ САЛЫСТЫРМАЛЫ БАҒАЛАУ // Ғылым және Денсаулық сақтау 2014.№ 1. С. 48-50Related publications:
THE DEMOGRAPHIC, CLINICAL AND SOCIAL CHARACTERISTICS OF PATIENTS WITH SCHIZOPHRENIA AND SCHIZOPHRENIA SPECTRUM DISORDERS
STUDY OF KOMPLAENTNOSTI FOR THERAPY OF PATIENTS WITH A HIGH CORONARY RISK
EARLY DIAGNOSIS OF METABOLIC SYNDROME IN CHILDREN AND TEENAGERS OF № 6 SCHOOL GYMNASIUM OF SEMEY
MONITORING OF EDUCATIONAL LEVEL OF DENTAL STUDENTS IN ORAL CAVITY HEALTH
СТОМАТОЛОГИЧЕСКИЙ СТАТУС ПАЦИЕНТОК НА ФОНЕ ПРИМЕНЕНИЯ СОПРОВОДИТЕЛЬНОЙ ТЕРАПИИ ПРИ ПРОВЕДЕНИИ ПРОТИВООПУХОЛЕВОЙ ХИМИОТЕРАПИИ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ